Welcome to Ainsley’s Unlock: The FDA Goes Generative

In this teaser episode, Ainsley, Will, Gosia, and Jay come together to launch Ainsley’s Unlock—a new podcast from Ainsley Advisory Group breaking down the business of healthcare AI. The team discusses venture trends, national policy shifts, and the latest in large language models, with a spotlight on how the FDA is beginning to deploy generative AI to streamline regulatory review. Plus, a look at the week’s biggest VC deals in biotech and the global race for AI infrastructure.